Multiparametric Magnetic Resonance Imaging Alone is Insufficient to Detect Grade Reclassification in Active Surveillance for Prostate Cancer-Reference-Cited by-同舟云学术

Multiparametric Magnetic Resonance Imaging Alone is Insufficient to Detect Grade Reclassification in Active Surveillance for Prostate Cancer

Published:2020-10 Issue:4 Volume:78 Page:515-517
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Chu Carissa E.^ORCID,Lonergan Peter E^ORCID,Washington Samuel L.^ORCID,Cowan Janet E,Shinohara Katsuto,Westphalen Antonio C.,Carroll Peter R.,Cooperberg Matthew R^ORCID

Publisher

Elsevier BV

Subject

Urology

Reference11 articles.

1. Active surveillance for prostate cancer: a narrative review of clinical guidelines;Bruinsma;Nat Rev Urol,2016

2. Active surveillance for the management of localized prostate cancer (Cancer Care Ontario guideline): American Society of Clinical Oncology clinical practice guideline endorsement;Chen;J Clin Oncol,2016

3. Negative predictive value of multiparametric magnetic resonance imaging in the detection of clinically significant prostate cancer in the Prostate Imaging Reporting and Data System era: a systematic review and meta-analysis;Sathianathen;Eur Urol,2020

4. Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology;Le;Eur Urol,2015

5. Some prostate cancers are invisible to magnetic resonance imaging!;Marks;BJU Int,2016

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PRECISE v2: An Enhanced Framework To Guide Future Research on the Use of Magnetic Resonance Imaging in Prostate Cancer Active Surveillance;European Urology;2024-09

2. Adequacy of clinical guideline recommendations for patients with low-risk cancer managed with monitoring: systematic review;Journal of Clinical Epidemiology;2024-05

3. Magnetic Resonance Imaging-guided Active Surveillance Without Annual Rebiopsy in Patients with Grade Group 1 or 2 Prostate Cancer: The Prospective PROMM-AS Study;European Urology Open Science;2024-01

4. Baseline prostate health index risk category and risk category changes during active surveillance predict grade reclassification;Urologic Oncology: Seminars and Original Investigations;2023-11

5. Prostate Cancer Radiological Estimation of Change in Sequential Evaluation (PRECISE) Magnetic Resonance Imaging Scoring to Predict Clinical Outcomes in Active Surveillance for Grade Group 1 Prostate Cancer;Urology;2023-10